Nabriva Therapeutics plc
NBRVF
$0.0001
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 21.36% | -85.52% | -15.25% | -26.91% | -40.68% |
| Total Receivables | -57.76% | 55.89% | -45.58% | 0.22% | 12.30% |
| Inventory | -- | -6.71% | -44.18% | 11.57% | -0.62% |
| Prepaid Expenses | 45.71% | 4.05% | -30.09% | -50.71% | 35.53% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -40.65% | 0.00% | 1.65% | -0.82% | -29.89% |
| Total Current Assets | -58.00% | -23.82% | -34.60% | -12.40% | -16.72% |
|
|
|||||
| Total Current Assets | -58.00% | -23.82% | -34.60% | -12.40% | -16.72% |
| Net Property, Plant & Equipment | -6.46% | -6.07% | -4.44% | 42.23% | 13.81% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -50.00% | -33.33% | -57.14% | -46.15% | -38.10% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.26% | 0.27% | -0.26% | -0.26% |
| Total Assets | -56.54% | -23.38% | -34.15% | -12.12% | -16.55% |
|
|
|||||
| Total Accounts Payable | 101.00% | 28.48% | 39.44% | 263.00% | -32.00% |
| Total Accrued Expenses | -24.60% | 46.54% | -26.13% | 11.04% | 22.96% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -0.51% | -95.92% | -15.70% | -13.45% | 57.86% |
| Total Finance Division Other Current Liabilities | -60.56% | 1.50% | 337.44% | -20.10% | -14.37% |
| Total Other Current Liabilities | -60.56% | 1.50% | 337.44% | -20.10% | -14.37% |
| Total Current Liabilities | -6.41% | 1.42% | 27.56% | 11.94% | 18.82% |
|
|
|||||
| Total Current Liabilities | -6.41% | 1.42% | 27.56% | 11.94% | 18.82% |
| Long-Term Debt | -0.29% | -11.08% | -2.76% | -22.07% | -86.93% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00% | -26.51% | -17.13% | 30.18% | -54.13% |
| Total Liabilities | -6.26% | 0.78% | 25.89% | 11.48% | -4.10% |
|
|
|||||
| Common Stock & APIC | 0.01% | 0.16% | 0.07% | 0.39% | 0.16% |
| Retained Earnings | -1.82% | -1.33% | -3.62% | -1.86% | -1.82% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | -274.59% | -232.31% | -87.15% | -25.96% | -22.45% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -274.59% | -232.31% | -87.15% | -25.96% | -22.45% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -274.59% | -232.31% | -87.15% | -25.96% | -22.45% |
|
|
|||||